Association of Histopathological Markers with Clinico-Pathological Factors in Mexican Women with Breast Cancer

作者: Cindy Bandala , Paloma De la Garza-Montano , Alfredo Cortes-Algara , Jaime Cruz-Lopez , Rene Dominguez-Rubio

DOI: 10.7314/APJCP.2015.16.18.8397

关键词:

摘要: BACKGROUND Breast cancer (BCa) is the most common malignancy in Mexican women. A set of histopathological markers has been established to guide BCa diagnosis, prognosis and treatment. Nevertheless, only a few health services, such as that Secretariat National Defense (SEDENA for its acronym Spanish), are these commonly employed assessing BCa. The aim this study was explore association Ki67, TP53, HER2/neu, estrogenic receptors (ERs) progesterone (PRs) with risk factors. MATERIALS AND METHODS Clinical histories provided background patient information. Immunohistochemical (IHC) analysis conducted on 48 tissue samples from women diagnosed treated radical mastectomy. Chi square test or Fisher exact together Pearson Spearman correlation were applied. RESULTS On average, patients 58±10.4 years old. It find invasive ductal carcinoma (95.8%), histological grade 3 (45.8%), poor Nottingham Prognostic Index (NPI; 80.4%). ERs PRs associated smoking alcohol consumption, metastasis at diagnosis Ki67 expression (p<0.05). PR+ also related urea ER+ TP53 elevated triglycerides (p<0.05), HER2/neu ER+, number pregnancies tumor size NPI (p <0.05) CD34 triple negative status (ER-/PR-/HER2/neu-) smoking, exposure biomass, pregnancies, Moreover, luminal B subtype type (p=0.007), (p=0.03) high cholesterol (p=0.02). CONCLUSIONS ER PR proved be several clinical pathological Hence, it crucial determine IHC profile Certain associations require further understand physiological/biochemical/molecular processes.

参考文章(36)
Bernard Seshie, Nii Armah Adu-Aryee, Florence Dedey, Benedict Calys-Tagoe, Joe-Nat Clegg-Lamptey, A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana BMC Clinical Pathology. ,vol. 15, pp. 14- 14 ,(2015) , 10.1186/S12907-015-0014-4
Jorunn E. Eyfjörd, Steinunn Thorlacius, Anne-Lise Börresen, Somatic p53 Mutations in Human Breast Carcinomas in an Icelandic Population: A Prognostic Factor Cancer Research. ,vol. 53, pp. 1637- 1641 ,(1993)
E De Azambuja, Fatima Cardoso, Gilberto de Castro, Mariantonietta Colozza, Max S Mano, Virginie Durbecq, Christos Sotiriou, Denis Larsimont, MJ Piccart-Gebhart, Marianne Paesmans, None, Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. British Journal of Cancer. ,vol. 96, pp. 1504- 1513 ,(2007) , 10.1038/SJ.BJC.6603756
D. P. Lane, p53, guardian of the genome Nature. ,vol. 358, pp. 15- 16 ,(1992) , 10.1038/358015A0
Richard M. Elledge, Suzanne A. W. Fuqua, Gary M. Clark, Pascal Pujol, D. Craig Allred, William L. McGuire, Prognostic significance of p53 gene alterations in node-negative breast cancer Breast Cancer Research and Treatment. ,vol. 26, pp. 225- 235 ,(1993) , 10.1007/BF00665800
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi, Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy Breast Cancer Research and Treatment. ,vol. 142, pp. 69- 80 ,(2013) , 10.1007/S10549-013-2691-Y
Naoki Niikura, Takayuki Iwamoto, Shinobu Masuda, Nobue Kumaki, Tang Xiaoyan, Masatoshi Shirane, Kazushige Mori, Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda, None, Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer Cancer Science. ,vol. 103, pp. 1508- 1512 ,(2012) , 10.1111/J.1349-7006.2012.02319.X
Margaret A. Gates, Mousheng Xu, Wendy Y. Chen, Peter Kraft, Susan E. Hankinson, Brian M. Wolpin, ABO blood group and breast cancer incidence and survival International Journal of Cancer. ,vol. 130, pp. 2129- 2137 ,(2012) , 10.1002/IJC.26220
Maricruz Anaya-Ruiz, Veronica Vallejo-Ruiz, Lilian Flores-Mendoza, Martin Perez-Santos, Female Breast Cancer Incidence and Mortality in Mexico, 2000-2010 Asian Pacific Journal of Cancer Prevention. ,vol. 15, pp. 1477- 1479 ,(2014) , 10.7314/APJCP.2014.15.3.1477